Curriculum Vitae

A. Personal Identity
Name : Prof. Dr. dr. Erlina Burhan, MSc, Sp.P(K)
Date of birth : Padang, May 15th 1963
Email : [email protected]; [email protected]

B. Academic History
Professor
Faculty of Medicine Universitas Indonesia–2024

PhD
Faculty of Medicine Universitas Indonesia–2012

Consultant of Respiratory Infection

Faculty of Medicine Universitas Indonesia–2010

Pulmonologist
Faculty of Medicine Universitas Indonesia–2004

Master of Science in Community Health

Heidelberg University, Germany–1995

Medical doctor
Faculty of Medicine, Universitas Andalas–1989

C. Training

APSR Webinar : Update on COVID-19 situation in Asia-Pacific Region

Osaka, Japan–2020

The 17th Scientific Respiratory Meeting (PIPKRA) TB MDR workshop

Jakarta, Indonesia–2020

Pneumonia Master Class: Standing Together Against Pneumonia

Jakarta, Indonesia–2020

The 24th Congress of the Asian Pacific Society of Respirology

Bangkok, Thailand–2019

The 50th Union World Conference on Lung Health: TB Science

Hyderabad, India–2019
 Meeting of Experts: Update on Excellent Services of Respiratory Hospital
Jakarta, Indonesia–2019

The 1st Annual Scientific Meeting of The Indonesian Society of Tropical and
Infectious Disease
Bandung, Indonesia–2018

Meet the Experts: Small Airways in Obstructive Lung Disease–Impact and

Extra Fine Particle on Symptom Control
Jakarta, Indonesia–2017

Good Clinical Practice Training

Jakarta, Indonesia–2017

The 7th Asian Pacific Congress on Bronchology and Interventional

Pulmonology
Bali, Indonesia–2017

D. Appointment
a. Organization
● 2023 – now Steering Committee TB Vaccine M72 Multinational
Clinical Trial (Bill & Melinda Gates Foundation)
● 2023 – now Head of Respiratory Care Indonesia (RESPINA)
● 2023 – now StopTB Partnership Global Board Member, Private
Sector Providers (Geneve, Switzerland)
● 2022 – 2025 Board Member of Director International Union
Tuberculosis and Lung Diseases (IUTLD) (Headquarter Paris,
France)
● 2018 – 2022 Board Member of Director International Union
Tuberculosis and Lung Diseases (IUTLD) (Headquarter Paris,
France)
● 2022 – now TB TV Founder and Host
(https://www.youtube.com/@TuberculosisTV)
● 2022 – now WHO consultant for TB Mission to Timor Leste
● 2015 – 2021 Head of TB Assembly Asian Pacific Society of
Respirology (APSR)
● 2018 – Now Chairperson of Respiratory and Tuberculosis
Research and Training Center (SATURATE)
● 2018 – 2021 Implementing Organization Public Private Mix TB
Indonesia (Director): 2018-2021 (Global Fund)
● 2013 – 2018 Member of The Regional Advisory Committee on
MDR-TB/rGLC, WHO SEARO
● 2009 now: Member of National CET for National Drug
Resistance TB Indonesia
● 2020 – now Head of Indonesia Coalition of Professional
Organization for Tuberculosis (KOPI TB)
● 2020 – now WHO Guideline Develpoment Group on COVID-19
Treatment
● 2015 – 2018 WHO Guideline Develpoment Group on DRTB
Treatment
● 2020 – now Head of COVID-19 Commando Team Persahabatan
National Lung Hospital
● 2020 – now Spokesman of COVID-19 Task Force Indonesian
Medical Association (IMA)
● 2018 – now Advisory Board Member Stop TB Partnership
Indonesia
● 2019 – 2021 Drug-Resistant TB Management for the National
TB Programme of Timor Leste
● 2018 – 2021 Board Member of Director International Union
Tuberculosis and Lung Diseases (IUTLD)
● 2017 – now Head of Advisory Board of The Indonesian
Association Against Tuberculosis (PPTI)
● 2017 – now Member of International Global Health Committee
American Thoracic Society
● 2016 – now Vice Chairman of TB Working Group Indonesia
● 2015 – 2021 Head of Indonesia Society of Respirology/PDPI
Jakarta Branch
● 2013 – now Principal Investigator and Steering Committee of
National Institute of Allergy and Infectious Diseases (NIAID),
Indonesia Research Partnership on Infectious Disease
(INA-RESPOND)
● 2013 – now Country Director of American Thoracic Society
(ATS) Methods in Epidemiologic, Clinical and Operations
Research (MECOR)
● 2013 – now Government Member of Guideline Latent TB
Infection
● 2013 – 2020 Head of Pulmonary Infection Division, Department
of Pulmonology and Respiratory Medicine, Faculty of Medicine,
Universitas of Indonesia
● 2013 – 2017 Research Coordinator of Pulmonology and
Respiratory Medicine, Faculty of Medicine, Universitas
Indonesia
● 2013 – 2016 Research Coordinator at Department of
Pulmonology and Respiratory Medicine, Faculty of Medicine,
Universitas of Indonesia
● 2012 – now Member of Indonesia Society of Respirology/PDPI
● 2010 – now Head of Foreign Affair, Indonesia Respiratory
Society, Head Quarter
 ● 2007 – now Vice Chairman of Task Force International Standard
for TB Care (ISTC) Indonesian Medical Association
● 2006 – now Head of TB DOTS and MDR-TB Persahabatan
Hospital Jakarta
● 2005 – now Member of Avian Influenza Team Persahabatan
National Lung Hospital
● 2004 - now Lecturer and clinical supervisor in Pulmonology
Department Faculty of Medicine Universitas Indonesia and
Persahabatan Hospital
b. Speaker / Lecturer
■ Summary of the main TRUNCATE-TB Trial results and
outstanding questions in Union World Conference 2023 (Paris)
■ Tuberculosis (TB) Public-Private Mix McGill Summer Institute
(McGill University, Canada): Making TB tools Available for
Private Sector Stakeholders
■ Drug-resistant TB - Is the era of personalized cocktails over, and
do we now have a single preferred regimen? Asian Pacific AIDS
& Coinfection Conference Singapore
■ Actual Issues of Management of Patients with Drug-Resistant
Tuberculosis, Implementation of Innovations in Practice
(dedicated to the 100th anniversary of the National Institute of
Physician and Pulmonology Ukraine)
■ Covid-19 in Indonesia in South East Asia Event Asia Pacific
Society of Respirology
■ Tracing system for covid in the population (representing Asia
Pacific Society of Respirology in Latin American Thorax
Association)
■ Annual speaker in Asia Pacific Society of Respirology
■ TB Research (Philippines)
■ Latent TB Infection (Malaysia)
■ Tobacco and TB (Singapore)
c. Reviewer & Editor
■ Guest Editor: Heliyon Cell
■ Reviewer:
1. BMC Global and Public Health "The neglected AIDS:
malnutrition must be addressed with the same urgency as
HIV to end tuberculosis" 2023
2. Heliyon “Classical monocytes-low expressing HLA-DR is
associated with higher mortality rate in SARS-CoV-2+
young patients with severe pneumonia.” 2023
3. Annals of Medicine (Elevate) “Effectiveness, Cost, and
Safety of Four Regimens Recommended by WHO for
RR/MDR-TB Treatment: a cohort study in Eastern China";
2023
 4. International Journal of Disaster Risk Reduction "The
mitigation strategies responding to the COVID-19
pandemic after reopening from the global perspective"
2023
5. Heliyon “Quantifying the differentiated global impact of
COVID-19 vaccines” 2023
d. Research

No. Title Role/ Year Sponsor/Collabor

Position ator

1. A Phase 3, randomized, National PI + 2023-now Bill and Melinda

double-blind, placebo-controlled, Steering Gates Foundation -
multicenter, clinical trial to assess Committee Medical Reseearch
the prophylactic efficacy, safety, Institute
and immunogenicity of the
investigational M72/AS01E-4
Mycobacterium tuberculosis (Mtb)
vaccine when administered
intramuscularly on a 0,1-month
schedule to adolescents and adults

2. A Randomized, Double-blind, National PI 2022 - Suzhou Abogen

Placebo-controlled Clinical Study to now Biosciences Co.
Evaluate the Efficacy, Safety, and Ltd.
Immunogenicity of SARS- CoV-2
Variant (BA.4/5) mRNA Vaccine
(ABO1020) in Healthy Subjects
Aged 18 Years and Older Who
Have Completed the Full
Vaccination

3. A Randomized, Double-Blind, and National PI 2022 - Suzhou Abogen

Placebo-Controlled Phase 1 Clinical now Biosciences Co.
Study to Evaluate the Safety, Ltd.
Tolerability, and Immunogenicity of
SARS-CoV-2 Variant mRNA Vaccines
(ABO1009-DP and ABO-CoV.617.2)
in Indonesian Subjects Aged 18
Years and Older Who Have Not
Received SARS-CoV-2 Vaccines
ABO1009-CoV.617.2-101-Indonesia

4. Two-Month Regimens Using Novel Country PI/ 2018 - University College

Combinations to Augment Treatment Site PI now London, National
Effectiveness for Drug-Sensitive University of
Tuberculosis Singapore

5. Tuberculosis Research of National PI 2017 - National Institute of

INA-RESPOND on Drug Resistance 2021 Allergy and
(TRIPOD) Study Infectious
Diseases (NIAID),
Amerika Serikat,
Indonesia
Research
Partnership on
 Infectious
Diseases
(INA-RESPOND)

6. Line Probe Assay (LPA) Evaluation, Principal 2019 - Japan International

Genoscholar on Tuberculosis Investigator 2020 Cooperation
Program in Indonesia Agency, NIPRO
Japan

7. A Randomized, Double-Blinded, Country PI 2021 - Yuxi Walvax

Placebo-Controlled, Multicentered now Biotechnology Co.
Phase III Clinical Study to Evaluate Ltd.
Protection Efficacy, Safety, and Walvax
Immunogenicity of SARS-CoV-2 Biotechnology Co.
mRNA Vaccine in Subjects Aged 18 Ltd.
Years and Older Suzhou Abogen
Biosciences Co.
Ltd.

8. Real-world effectiveness of Principal 2021 - AstraZeneca

ChAdOx-1s, CoronaVac, BBIBP-CorV, Investigator now
and mRNA-1273 in Jakarta:
test-negative design study based in
existing health care data sources

9. Efficacy and Safety of BDB-001 Country PI 2020 - Staidson (Beijing)

Injection for COVID-19 with Severe now Biopharmaceutical
and Progressive Pneumonia s Co. Ltd., China
Treatment: A Multicentered,
Randomized, Opened, Compared,
and Parallel Phase II/III Clinical Study

10. Mesenchymal Stem Cell from Site PI 2020 - UPT Sel Punca
Umbilical Cord as Severe COVID-19 2021 RSCM SCTE
Pneumonia Therapy IMERI, Kementrian
Riset dan
Teknologi/BRIN,
Indonesia

11. A Randomized, Double-Blinded, Country PI 2020 - PT Kalbe

Placebo-Controlled, Parallel-Group, now Genexine
Single Dose Phase II Clinical Study to Biologics,
Evaluate Safety and Advantage of Indonesia
GX-I7 for Asymptomatic or Genexine, Inc.,
Symptomatic Elderly with Severe Korea
SARS-CoV-2 Infection

12. A multi-centre, Randomized, Site PI 2020 - ImmuneMed,

Double-blind, Parallel Design, Phase 2021 Korea
2 Study to Evaluate the Efficacy and
Safety of hzVSFv13 Compared to
Standard of Care After Intravenous
(IV) Administration With Add-on
Standard of Care in COVID-19
Moderate to Severe Patients

13. A Randomized Controlled Clinical Chief PI 2020 - PT Rhea Sciences

Trial to Evaluate Efficacy and Safety now Indonesia
of Health Tone as COVID-19
 Prophylaxis for Human Resources of
Persahabatan National Hospital

14. Safety and Effectivity of Remdesivir Chief PI 2021 - Badan Pengawas

for COVID-19 Patient Post EUA now Obat dan
(Emergency Use Authorization) Makanan, Republik
Administration. Indonesia

15. A Randomized, Double-Blinded Chief PI 2021 - Litbangkes,

Clinical Trial to Compare Efficacy now Kementrian
Between 5 and 10 days Remdesivir Kesehatan,
Administration for Moderate to Severe Republik Indonesia
COVID-19 Inpatient

17. A Randomized, Open-Label, Chief PI 2020 - PT. Neumedik

Controlled Clinical Study to Evaluate 2021 Indonesia, PT
Efficacy and Safety of AVIMAC as Equilab
Adjuvant Therapy for Mild to Moderate International
COVID-19 Receiving Standard
Therapy

18. A randomized double-blind Site PI 2018 - Oxford University

placebo-controlled trial of adjunctive 2020 Clinical Research
dexamethasone for the treatment of Unit
HIV-infected adults with tuberculous
meningitis (ACT-HIV Trial)

19. The COVID-19 Critical Care Site PI 2020 Clinical Care

Consortium Research group,
Extracorporeal Life
Support
Organization, Irish
Critical Care
Clinical Trials
Group, Irish Critical
Care Clinical Trials
Network,
International
ECMO Network

20. Evaluating new Sputum-Based 2014 Departemen

Methods for Monitoring Bacterial Pulmonologi dan
Response to TB Therapy: Bacterial Ilmu Kedokteran
Transcriptomics and Resuscitation Respirasi Fakultas
Promoting Factor (RPF)-Dependent Kedokteran
Culture Techniques Universitas
Indonesia

21. Pengembangan Uji Urin pada Pasien 2019 Fakultas

Terduga Infeksi Tuberkulosis (TB) Kedokteran
dengan Kelangkaan Sputum Universitas
Indonesia

22. Profil Klinis Pasien COVID-19 yang 2020 PT Bio Farma,

menggunakan Oseltamivir dan HCQ Indonesia

23. Evaluasi Penggunaan Line Probe 2019 - Japan International

Assay (LPA), Genoscholar pada 2020 Cooperation
Program Tuberkulosis di Indonesia Agency, NIPRO
 Japan

24. Prevalensi Pasien Tuberkulosis di 2020 Kementrian Riset,

Rumah Sakit Umum Persahabatan Teknologi, dan
Selama Pandemi Corona Virus Pendidikan Tinggi
Disease-19 Republik Indonesia

25. Prevalensi dan Karakteristik Pasien 2020 Indonesian Medical

dengan Infeksi Nontuberculous Education and
Mycobacteria (NTM) Research Institute

E. Publication & Books

No. Title Author Publication

1 Treatment Strategy for Paton NI, Cousins C, New England Journal
Rifampin-Susceptible Suresh C, Burhan E, Chew of Medicine. 2023 Mar
Tuberculosis KL, Dalay VB, Lu Q, 9;388(10):873-87.
Kusmiati T, Balanag VM,
Lee SL, Ruslami R

2 Characteristics of Burhan E, Karyana M, The American Journal

Drug-sensitive and Karuniawati A, Kusmiati T, of Tropical Medic2ine
Drug-resistant Tuberculosis Wibisono BH, Handayani and Hygiene. 2022 Oct
Cases among Adults at D, Riyanto BS, 17:tpmd220142-.
Tuberculosis Referral Sajinadiyasa IG, Sinaga
Hospitals in Indonesia BY, Djaharuddin I, Susanto
NH.

3 Performance of Xpert Karuniawati A, Burhan E, Frontiers in Medicine 9

MTB/RIF and sputum Koendhori EB, Sari D, (2023): 909198
microscopy compared to Haryanto B, Nuryastuti T,
sputum culture for diagnosis Gayatri AY, Bahrun U,
of tuberculosis in seven Kusumawati RL, Sugiyono
hospitals in Indonesia RI, Susanto NH

4 Evaluation of safety and Burhan, E., Syahruddin, Frontiers in

effectiveness of remdesivir E., Isbaniah, F., Desianti, Pharmacology, 14,
in treating COVID-19 G.A., Fachrucha, F., Sari, p.1205238.
patients after emergency C.Y.I., Ismail, E., Astuti, P.,
use authorization study Maruli, M.F., Mubarak, F.
and Rengganis, A.T.

5 Association between Burhan, E., Farhan Frontiers in Medicine

cardiovascular diseases Mubarak, Siti Aliyah Said 2023
and COVID-19 pneumonia Utriyani Adilah, Cut Yulia
outcome in Indonesia: a Indah Sari, Efriadi Ismail,
multi-center cohort study Puji Astuti, Yasmina
Hanifah, Elvan Wiyarta,
and Nana Maya Suryana.

6 Double-Blind, Randomized, Prasenohadi, P., Burhan, Journal of Clinical

Placebo-Controlled Study E., Dhunny, S., Suharno, Medicine 2022
on hzVSF-v13, a Novel W., Wabnitz, P., Kim, Y. W.,
Anti-Vimentin Monoclonal & Petrosillo, N
 Antibody Drug as Add-on
Standard of Care in the
Management of Patients
with Moderate to Severe
COVID-19

7 Community Smoking Tjandra Yoga Aditama, Jurnal Respirologi

Cessation Activities in Caecilia Arimah, Elisna Indonesia (JRI), Vol 26
Jakarta Syahruddin, Erlina Burhan no.3 Juli 2006, hal
130-136

8 Efikasi Prosedur Diagnosis Menaldi Rasmin, Elisna Jurnal Respirologi

dan Akurasi Diagnosis Syahruddin, Anwar Jusuf Indonesia (JRI), Vol
Sitologi Prabedah Kanker dan Erlina Burhan 26 no.4 Oktober 2006,
Paru hal 185 - 194

9 Akurasi Staging Prabedah Menaldi Rasmin, Elisna Jurnal Respirologi

(ctNM) Pasien Kanker Paru Syahruddin, Anwar Jusuf, Indonesia (JRI), Vol
Jenis Karsinoma Bukan Sel Erlina Burhan 26 no.4 Oktober 2006,
Kecil yang menjalani hal 202 - 205
pembedahan

10 Angka Tahan Hidup Erlina Burhan, Nirwan Jurnal Respirologi

Penderita Kanker Paru jenis Arief, Ahmad Hudoyo, Indonesia (JRI), Vol
Karsinoma Bukan Sel Kecil Eddy Suratman, Anwar 26 no.4 Oktober 2007,
yang layak dibedah Jusuf, Elisna Syahruddin, hal 214 – 213
Bambang Sutrisna

11 Avian Influenza in 8 patients Priyanti ZS, Hadiarto M, 12th Congress of the

in Persahabatan Hospital Mukhtar I, Tjandra YA, APSR/2nd Joint
Erlina B, Boedi S Congress of The
APSR/ACCP pada
tanggal 30 November
30 – 5 Desember,
2007 di Queensland,
Australia

12 Hasil pengobatan Priyanti ZS, Hadiarto Medika 2008, Tahun

pneumonia komuniti Mangunnegoro, Erlina XXXIV no.9 .p. 608-
dengan strategi terapi sulih Burhan dan Fathiyah 612
fosfomycin intravena Isbaniah
cefditoren oral

13 A Comparative Study of Priyanti ZS, dr. Erlina B, Dibawakan pada acara

The In-Vitro Activity of dr. Fathiyah, dr. Pratiwi S Kongres APSR di
Levofloxacin and 15 Other Bangkok, Thailand
Antibiotics Among Bacterial tanggal 18 – 23
Isolates Causing Acute November 2008
Bacterial Exacerbation of
Chronic Obstructive
Pulmonary Disease
(ABECOPD) in Selected
Asian Countries

14 Levofloxacin in acute Priyanti Soepandi, Arifin Medical Progress,

exacerbations of infected Nawas, Achmad April 2009 Vol. 36
bronchiectasis Widiatmoko, Erlina No. 4
Burhan, Fathiyah Isbaniah
15 Avian influenza cases in Priyanti Soepandi, Arifin Journal Asia Pasific
Persahabatan Hospital Nawas, Erlina Burhan Society of Respirology,
Jakarta, Epidemiology and Vol. 14, hal. A135,
Clinical Pattern Sup. 3, November
2009

16 Factors affecting failure of Priyanti Soepandi, Arifin Journal Asia Pasific

water sealed drainage in Nawas, Erlina Burhan Society of Respirology,
management of Vol. 14, hal. 231, Sup.
tuberculosis empyema in 3, November 2009
Persahabatan Hospital

17 Identifikasi faktor risiko Dedi Nofizar, Arifin Maj.Kedokt.IndonVolu

tuberkulosis Multidrug Nawas, Erlina Burhan m : 60 : No : 12,
Resistance (TB-MDR) Desember 2010

18 Fisiologi Tidur dan Arief Riadi Arifin Ratnawati, Jurnal Respirologi

pernapasan Erlina Burhan Indonesia (JRI), Vol 30
no.1 januari 2010, hal.
39 – 45

19 Characteristics and Risky Akaputra, Erlina J Respir Indo. 2013;

Evaluations of Illness of Burhan, Arifin Nawas 33:92-102
Multidrug Resistant
Tuberculosis with and
Without Diabetes Mellitus

20 Penilaian respons Fikri Faisal, Erlina Burhan, Jurnal Respirologi

pengobatan empiris pada Wahyu Aniwidyaningsih, Indonesia (JRI), Vol 34
pasien rawat inap dengan Aria Kekalih no. 2 April 2014, hal.
pneumonia komunitas 60 - 70

21 Faktor terjadinya Agung Wijayanto, Erlina Jurnal Respirologi

tuberkulosis paru pada Burhan, Arifin Nawas, Indonesia vol.35 no. 1
pasien diabetes mellitus Rochsismandoko Januari 2015 hal. 1–11
Tipe 2

22 Uji banding pemeriksaan Sukara Safril Kusuma Jurnal Respirologi

mikroskopis sputum basil Jaya, Indonesia vol.35 no. 3
tahan asam dengan Xpert Erlina Burhan, Juli 2015 hal. 144–157
Mtb/RIF pada pasien Rochismandoko, Cahyarini
diabetes mellitus yang
diduga tuberkulosis paru

23 Peranan prokalsitonin pada Mirza Purwitasari, Erlina Journal of infectious

pneumonia komunitas Burhan, Priyanti ZS diseases. Vol 2 No. 02
tahun. 2015. hal 33
–41

24 Faktor yang Mempengaruhi Iceu Dimas Kulsum, Erlina Asian J Pharm Clin
Konversi Sputum BTA Burhan, Rochismandoko Res, Vol 10, Issue 11,
Mikroskopik pada Pasien 2017, 194-198
Tuberkulosis Paru Kasus
Baru dengan Diabetes
Mellitus

25 The Impact Of Nisa Maria, Maksum Radji, Asian J Pharm Clin

Antituberculosis Erlina Burhan Res, Vol 10, Issue 11,
Drug-Induced 2017, 194-198
 Hepatotoxicity To Succesful
Tuberculosis
Treatment In Indonesia

26 Infeksi Jamur Paru di Anna Rozaliyani, Anwar J Respir Indo Vol. 39

Indonesia: Situasi Saat Ini Jusuf, Priyanti ZS, Erlina No. 3 Juli 2019 hal.
dan Tantangan di Masa Burhan, Diah Handayani, 211 – 215
Depan Henie Widowati, Satria
Pratama, Findra
Setianingrum

27 Tuberkulosis Multidrug Erlina Burhan Maj.Kedokt.Indon,

Resistance (TB-MDR) Volum : 60 : No : 12,
Desember 2010

28 Peran ISTC dalam Erlina Burhan Jurnal Tuberkulosis

pencegahan MDR Indonesia Vol. 7
Oktober 2010

29 RSUP Persahabatan jadi Erlina Burhan Jurnal Persahabatan

rujukan tuberculosis Hopsital, edisi 7, 2017

30 Miliary Tuberculosis & Ditta Adelia Hadisubrata, Jurnal Tuberkulosis

Pharyngo-laryngitis Wiwien Heru Wiyono, Indonesia Vol. 6 Juli
Tuberculosis : A Case Erlina Burhan 2009
Report

31 Diagnosis dan Ni Made Restiawati Jurnal Respirologi

penatalaksanaan Erlina Burhan Indonesia (JRI), Vol
Mycobacterium other than 31 no.3 Juli 2011, hal.
tuberculosis (MOTT) 156 – 64

32 Clinical course of avian Priyanti ZS, Erlina Burhan, CHEST/ 138/3

influenza A(H5N1) in Hadiarto M, Arifin Nawas, September 2010
patients at the Tjandra Yoga A, Lia
Persahabatan Hospital, Partakusuma, Fathiyah
Jakarta, Indonesia Isbaniah, Mukhtar Ikhsan,
2005-2008 Boedi Swidarmoko, Agung
Sutiyoso, Suhud Malik,
Rachel Benamore,
MBBChir, J.Kevin Baird
and Walter RJ Taylor

33 A multicentre surveillance Respirology (2011)

study on the characteristics, David S. Hui, Margaret Ip, 16, 532–539
bacterial aetiologies and in Thomas Ling, Shan-Chwen doi: 10.1111/j.1440-
vitro antibiotic Chang, Chun-Hsing Liao, 1843.2011.01943.x
susceptibilities in patients Chul-Gyu Yoo,
with acute exacerbations of Deog-Kyeom Kim, Ho-Il
chronic bronchitis Yoon, Visit Udompanich,
Somkid Mogmeud, Razak
Muttalif, Azmi M. Salleh,
Camilo Roa, Myrna
Mendoza, Concepcion
Fajardo-Ang, Priyanti
Soepandi, Fathiyah
Isbaniah, Erlina Burhan,
Pratiwi Sudarmono,
Hadiarto Mangunnegor O
 And Hans H. Liu

34 Avian influenza e A review W.R.J. Taylor, E. Burhan c, Travel Medicine and

for doctors in travel H. Wertheim, P.Z. Soepandi Infectious Disease
medicine c, P. Horby, A. Fox, R. (2010) 8, 1e12
Benamore, L. de Simone,
T.T. Hien, F. Chappuis

35 Isoniazid, Rifampin, and Erlina Burhan, Carolien Antimicrobial Agents

Pyrazinamide Plasma Ruesen, Rovina Ruslami, and Chemotherapy p.
Concentrations in Relation Arum Ginanjar, Hadiarto 3614–3619 August
to Treatment Response in Mangunnegoro, 2013 Volume 57
Indonesian Pulmonary Purwantyastuti Ascobat, Number 8
Rogier Donders, Reinout
van Crevel, Rob Aarnoutsef

36 Effects of introducing Xpert Sanne C,Van Kampen, DOI: 1371/journal

MTB/RIF on diagnosis and Nugroho H Susanto, plos one 2015 .p. 1 – 7
treatment of drug-resistant Sumanto Simon, Shinta
tuberculosis patients in D.Astiti, Roni Chandra,
Indonesia : A Pre-post E.Burhan, Muhammad
invention study N.Farid, Kendra
Chittenden,
Dyah E.Mustikawati, Bachti
Alisjahbana

37 Losing the fight against E.Burhan The New York Times

tuberculosis 2015 p. 1 – 4

38 Supporting progress toward Toru Mori, E.Burhan Eur Respir J 2015; 45:
the post 2015 targets and 1760 – 1762
regional tuberculosis
elimination: a statement of
intent from the third meeting
of the Asian TB Experts
Community

39 Management of latent Haileyesus Getahun, Eur Respir J 2015; 46:

Mycobacterium tuberculosis Alberto Matteelli, Ibrahim 1563–1576 | DOI:
infection: WHO guidelines Abubakar, Mohamed Abdel 10.1183/13993003.01
for low tuberculosis burden Aziz, Annabel Baddeley, 245-2015
countries Draurio Barreira, Saskia
Den Boon,Susana Marta
Borroto Gutierrez, Judith
Bruchfeld, Erlina Burhan,
Solange avalcante,
Rolando Cedillos, Richard
Chaisson, Cynthia Bin-Eng
Chee, Lucy Chesire,
Elizabeth Corbett, Masoud
Dara, Justin Denholm,
Gerard de Vries, Dennis
Falzon, Nathan Ford,
Margaret Gale-Rowe, Chris
Gilpin, Enrico Girardi,
Un-Yeong Go, Darshini
Govindasamy, Alison D.
Grant, Malgorzata
 rzemska, Ross Harris, C.
Robert Horsburgh Jr, Asker
Ismayilov, Ernesto
Jaramillo, Sandra Kik,
Katharina Kranzer,
Christian
Lienhardt, Philip LoBue
Knut Lönnroth1,Guy
Marks, Dick Menzies,
Giovanni Battista Migliori,
Davide Mosca, Ya Diul
Mukadi, AlwynMwinga, Lisa
Nelson, Nobuyuki
Nishikiori, Anouk
Oordt-Speets,
Molebogeng Xheedha
Rangaka, Andreas
Reis,Lisa Rotz, Andreas
Sandgren, Monica Sañé
Schepisi, Holger J.
Schünemann, Surender
Kumar Sharma, Giovanni
Sotgiu, Helen R.
Stagg,Timothy R. Sterling,
Tamara Tayeb, Mukund
Uplekar, Marieke J. van der
Werf, Wim Vandevelde,
Femke van Kessel, Anna
van‟t Hoog, Jay K. Varma,
Natalia Vezhnina,
Constantia Voniatis, Marije
Vonk Noordegraaf-
Schouten, Diana Weil,
KarinWeyer, Robert John
Wilkinson, Takashi
Yoshiyama, Jean Pierre
Zellweger and Mario
Raviglione

40 ORIGINAL ARTICLE Ari Probandari, Bagoes Citation: Glob Health

The path to impact of Widjanarko, Yodi Action 2016, 9: 29866
operational research on Mahendradhata, Hary -
tuberculosis control policies Sanjoto, Ancila Cerisha, http://dx.doi.org/10.34
and practices in Indonesia Saverina Nungky, Pandu 02/gha.v9.29866
Riono, Sumanto Simon,
Muhammad Noor Farid,
Sardikin Giriputra, Artawan
Eka Putra, Erlina Burhan,
Chatarina U. Wahyuni,
Dyah Mustikawati,
Christina
Widianingrum, Edine W.
Tiemersma, Bachti
Alisjahbana

41 Molecular Diagnosis of Fariz Nurwidya, Diah Chonnam Med J

Tuberculosis Handayani, Erlina Burhan, 2018;54:1-9
and Faisal Yunus
42 The Relationship between Ratnawati, Dewi Wijaya, [Downloaded free from
Hemoglobin A1C Levels Ahmad Muslim Nazaruddin, http://www.jnsbm.org
and Fariz Nurwidya, Erlina on Wednesday,
Sputum Conversion Time in Burhan October 24, 2018, IP:
Indonesian Patients with 110.138.155.193]
New Cases of Pulmonary Journal of Natural
Tuberculosis Science, Biology &
Medicine Vol 9 Issue 2;
Juli – Desember 2018

43 Tuberculosis Elimination in Justin T. Denholm, Diego Trop. Med. Infect. Dis.

the Asia-Pacific Region and S. Silva, Erlina Burhan, 2018, 3, 115;
the WHO Ethics Guidance and doi:10.3390/tropicalme
Richard E. Chaisson d3040115

44 Adjunctive dexamethasone Joseph Donovan, Nguyen Welcome Open

for the treatment of Hoan Phu, Nguyen Thi research 2018, 3 : 31
HIV-infected adults with Hoang Mai, Le Tien Dung, Last Update : 17 Sep
tuberculosis meningitis Darma Imran, Erlina 2018
(ACT HIV) : Study protocol Burhan, Lam Hong Bao
for a randomized controlled Ngoc, Nguyen Duc Bang,
trial (version 2; referees : 1 Do Chau Giang, Dang Thi
approved, 2 approved with Minh Ha, Jeremy Day, Le
reservations) Thi Phuong Thao, Nguyen
TT Thuong, Nguyen nang
Vien, Ronald B Geskuas,
Marcel Wolbers, Raph L
Hamers, Reinout van
Crevel, Mugi Nursaya,
Kartika Maharani, Tran
Tihn Hien, Kevin Baird,
Nguyen Huu Lan, evelyn
Kestelyn,
Nguyen Van Vinh Chau,
Guy E Thaiwates.

45 Comparison of Tuberculin Ratnawati, Erlina Burhan, Journal of Natural

Skin Test and Interferon – Cempaka Nova Intani, Heni Science, Biology &
Gamma Release Assay in Handayani, Fariz Nurwidya Medicine Vol 10 Issue
The Diagnosis of Latent 1; Januari – June 2019
Tuberculosis infection
among Indonesia
Health-Care Workers

46 Pneumococcal pneumonia Gina Amanda, Dianiati Reviews • DOI:

and invasive pneumococcal Kusumo Sutoyo, Erlina 10.2478/pneum-2019-0
disease: Burhan 009 • 68 • 2019 • 8-14
immunopathogenesis and published by Sciendo
diagnosis https://content.sciendo.
com/view/journals/pne
um/68/1/pneum.68.issu
e-1.xml

47 Cost-Sensitive Machine Ali Akbar Septiandri, medRxiv preprint first

Learning Classification for Aditiawarman, Roy Tjiong, posted online Jun. 28,
Mass Tuberculosis Erlina Burhan and Anuraj 2019 ; doi:
Screening H. Shankarz http://dx.doi.org/10.110
1/19000190
48 A novel diagnosis scoring Anna Rozaliyani, MD, PhD, Saudi Med J 2019;
model to predict invasive Rudyanto Sedono, MD, Vol. 40 (2)
pulmonary aspergillosis in Anwar Jusuf, MD, PhD, www.smj.org.sa
the intensive care unit Cleopas M. Rumende, MD,
PhD, Wahju
Aniwidyaningsih, MD, PhD,
Erlina Burhan, MD, PhD,
Prasenohadi, MD, PhD,
Diah Handayani, MD, Evy
Yunihastuti, MD, PhD,
Forman E. Siagian, MD,
PhD, Achmad M.
Jayusman, MD, Adria
Rusli, MD, Saleha Sungkar,
MD, Joedo Prihartono, MD,
Ferry Hagen, PhD,
Jacques F. Meis, MD, PhD,
Retno
Wahyuningsih, MD, PhD.

49 The influence of Harsini, Erlina Burhan, Received on:

interferon-gamma +874 T/A Afiono Agung Prasetyo, 12-03-2019; Revised
and interleukin-10 −1082 Suradi Suradi, Reviono, on: 18-05-2019;
G/A polymorphisms on Yusup Subagio Sutanto, Accepted
culture conversion in Dewi Makhabah, N. on: 25-06-2019
Javanese Ambrosino
multidrug-resistant
tuberculosis patients

50 A systematic review of Erlina Burhan, Ummul Medical Journal of

respiratory infection due to Mukminin Indonesia. Med J
air pollution during natural Indonesia 2020;29(1)
disasters

51 The Effect of Several Erike A.Suwarsono, Agus Advanced Science

Different Decontaminant Sjahrurachman, Anis Letters, Vol 24, number
Solutions for Sputum in Karuniawati, Erlina 9, September 2018,
Inhibiting Contaminating of Burhan pp.6930 – 6933 (4)
Mycobacterium
Tuberculosis
Culture

52 Effect of financial support Ahmad Fuady, Tanja AJ, Fuady et al. Infectious
on Houweling, Muchtaruddin Diseases of Proverty
reducing the incidence of Mansyur, Erlina Burhan (2019) 8:10
catastrophic costs among and Jan Hendrik Richardus
tuberculosis-effected
household in Indonesia :
eight simulated scenarios

53 Clinical Progression of Erlina Burhan, Acta Med Indones –

Covid-19 Patient with Prasenohadi, Indones J Intern Med.
extended Incubation Period, Rita Rogayah, Fathiyah Vo.52 Number 1
delayed RT-PCR Isbaniah, Tina Resia, January 2020
Time-to-positivity and Ibrahim Dharmawan
potential role of chest CT
scan

54 Protokol Talaksana Erlina Burhan, Agus Dwi Perhimpunan Dokter

 Covid-19 Susanto, Sally A Nasution, Paru Indonesia
Eka Ginanjar, Ceva
Wicaksono Pitoyo, Adityo
Susilo, Isman Firdaus,
Anwar Santoso, Dafsah
Arifa Juzar, Syafri Kamsul
Arif, Navy G.H Lolong
Wulung, Triya Damayanti,
Wiwien Heru Wiyono,
Prasenohadi, Fathiyah
Isbaniah, Diah Handayani,
Soedarsono, Harsini, Jane
R Sugiri, Afiatin, Edy Rizal
Wahyudi, Tri Juli Edi
Tarigan, Rudy Hidayat,
Faisal Muchtar, Cleopas
Martin Rumende, Arto
Yuwono Soeroto, Erwin
Astha Triyono, Sudirman
Katu, Tim COVID-19 IDAI

55 Tanggap Pandemi Covid-19 Menaldi Rasmin, Erlina Medical Education Unit

2020 (Buku Rancangan Burhan Agus Dwi Susanto, Fakultas Kedokteran
Pengajaran/BRP) Rr. Diah Handayani, Universitas Indonesia
Praseno Hadi, Rita 2019-2020
Rogayah, Erlang
Samoedro, Fathiyah
Isbaniyah, Adityo Susilo,
Cleopas Martin Rumende,
Andi Ade Wijaya, Anggara
Gilang Dwiputra, Anis
Karuniawati, Retno Asti
Werdhani, Wismandari
Wisnu, Syska Widyawati,
Dina Muktiarti, Oktavinda
Safitry, Nani Cahyani
Sudarsono

56 Standar Alat Pelindung Diri Akmal Taher, Zubairi Gugus Tugas

(APD) untuk Penanganan Djoerban, Menaldi Rasmin, Percepatan
Covid-19 di Indonesia Amin Soebandrio, Herawati Penanganan Covid-
Sudoyo, Agus Dwi 19
Susanto,
Erlina Burhan, Anis
Karuniawati, Budi
Sampurna, Ari Fahrial
Syam, Bambang
Supriyatno, Aditya Susilo,
Prasenohadi.

57 Informatorium Obat Rianto Setiabudi, Arini Badan Pengawas Obat

Covid-19 di Indonesia Setiawati, Faisal Yunus, dan Makanan Republik
Lucky S.Slamet, Erlina Indonesia (cetakan
Burhan, Cleopas Martin pertama 2020)
Rumende, Elin Yulinah,
Arry Yanuar, Antonia Retno
Tyas Utami, Endang Woro
T, Dewi Selvina Rosdiana,
Anggi Gayatri, Retnosari
 Andrajati

58 Pedoman Penanganan Mohammad Subuh, Gugus Tugas

Cepat Medis dan Slamet, Akmal Taher, Percepatan
Kesehatan Masyarakat Tugas Ratmono, Amin Penanganan Covid-19
Covid-19 di Indonesia Soebandrio, Meiwita P. Maret 2020
Budiharsana, Herawati
Sudoyo, Aryati, Agus Dwi
Susanto, Erlina Burhan

59 Panduan Praktik Klinik Agus Dwi Susanto, Erlina Perhimpunan Dokter

(PPK) Burhan Paru Indonesia

60 Protokol Rejimen Agus Dwi Susanto, Erlina Perhimpunan Dokter

Pengobatan Covid-19 untuk Burhan Paru Indonesia
Pedoman Nasional

61 Tatalaksana Pasien Agus Dwi Susanto, Erlina Perhimpunan Dokter

Covid-19 Burhan Paru Indonesia

62 Modul Gerakan Dokter Erlina Burhan Satgas Waspada dan

Semesta siaga Covid-19 PB IDI
Perhimpunan Dokter
Paru Indonesia (PDPI)

63 Petunjuk Pencegahan Erlina Burhan Satgas Waspada dan

Penularan Covid-19 Tenaga siaga Covid-19 PB IDI
Kesehatan Perhimpunan Dokter
Paru Indonesia (PDPI)

64 Etiologi, Transmisi, Erlina Burhan Satgas Waspada dan

Epidemiologi, Patogenesis, siaga Covid-19 PB IDI
Patofisiologi dan Defisini Perhimpunan Dokter
Kasus Covid-19 Paru Indonesia (PDPI)

65 Tatalaksana Covid-19 Erlina Burhan Satgas Waspada dan

siaga Covid-19 PB IDI
Perhimpunan Dokter
Paru Indonesia (PDPI)

66 Diagnosis Covid-19 Erlina Burhan Satgas Waspada dan

siaga Covid-19 PB IDI
Perhimpunan Dokter
Paru Indonesia (PDPI)

67 Pneumonia Covid-19 Erlina Burhan, Fathiyah Perhimpunan Dokter

Diagnosis & Isbaniah, Agus Dwi Paru Indonesia
Penatalaksanaan di Susanto Tjandra Yoga
Indonesia Aditama, Soedarsono,
Teguh Rahayu Sartono,
Yani Jane Sugiri, Rezki
Tantular, Bintang YM
Sinaga, R.R Diah
Handayani, Heidy Agustin
 F. Awards & Grants

Grant for Contribution to COVID-19 Management in Indonesia

PPKM Award 2023, Ministry of Health Republic Indonesia

Achmad Bakrie Award PAB XVIII 2022

Most Inspirational Health Workers

Ministry of Health Republic Indonesia, 2021

Most Outstanding Lecturer

Universitas Indonesia, 2020

Figure of Change–Republika National News Award

Republika National News Agency, 2020

Most Inspirational Pulmonology Consultant

Respirology National Referral Persahabatan Hospital, 2014

Satyalencana Karya Satya National Honorary Mark

President of The Republic Indonesia, 2012

Grant Recipients for The Tropical Health Postgraduate Program on Diagnosis

and Management of Multiple Drug Resistant Tuberculosis Elective Module
Compilation. Faculty of Medicine Universitas Indonesia, 2011

Date : 13 July 2023

Signature :